5 Stocks to Buy According to Francis Chou’s Chou Associates Management

3. Bausch Health Companies Inc. (NYSE:BHC)

Chou Associates Management’s Stake Value: $17,480,000
Percentage of Chou Associates Management’s Portfolio: 9.3%
Number of Hedge Fund Holders: 48

Together with its subsidiaries, Bausch Health Companies Inc. (NYSE:BHC) creates, produces, and distributes a variety of pharmaceuticals, medical devices, and over-the-counter (OTC) drugs, particularly in the fields of dermatology, gastroenterology, and eye health.

With a $793.38 million stake in Bausch Health Companies Inc. (NYSE:BHC), Carl Icahn’s Icahn Capital LP owned 34.72 million shares of the company as of the end of the first quarter of 2022, making it the most significant shareholder of the company. In addition, our database shows that 48 hedge funds held stakes in Bausch Health Companies Inc. (NYSE:BHC) as of the end of the first quarter of 2022, versus 53 funds in the fourth quarter of 2021.

On June 13, JPMorgan analyst Chris Schott initiated coverage of Bausch Health Companies Inc. (NYSE:BHC) and assigned an Overweight rating and a price objective of $12. The hedge fund managed by Chou owned 765,000 shares in Bausch Health Companies Inc. (NYSE:BHC), worth over $17.48 million, representing close to 9.3% of its portfolio.